知镜 Cognispect · 医学文献与研究工作台

Inflammation and the Association of Early-stage Cardiovascular-Kidney-Metabolic Syndrome with Incident Cardiovascular Disease and All-cause Mortality: Findings from the CARDIA and MESA Cohorts.

Tian L, Vu THT, Jacobs DR, Schreiner PJ, Shah NS, Lewis CE, Khan SS, Bhatt A, Wilkins JT, Allen NB, Lloyd-Jones DM, Greenland P, Rasmussen-Torvik LJ, Carnethon MR, Feinstein MJ.
American heart journal · 2026-11-15 · PMID 43035156

文献摘要

Background Limited data exist on whether inflammation modifies the association between early-stage cardiovascular-kidney-metabolic (CKM) syndrome and clinical events. Methods We included 9,894 participants free of cardiovascular disease (CVD) from the Coronary Artery Risk Development in Young Adults study (CARDIA, Year 20, 2005-2006) and the Multi-Ethnic Study of Atherosclerosis (MESA, Exam 1, 2000-2002). We examined whether interleukin-6 (IL-6; primary) and high-sensitivity C-reactive protein (hsCRP; ≥2 mg/L; secondary) modified associations of early-stage CKM syndrome (stages 2-3 vs 0-1) with incident CVD and all-cause mortality. IL-6 was dichotomized at cohort- and sex-specific medians. Cohort-stratified Cox models were adjusted for age, sex, race/ethnicity, education, smoking, and physical activity; multiplicative and additive effect modification were assessed. Results During follow-up, 1,635 atherosclerotic CVD events, 567 heart failure events, and 2,593 deaths occurred. After adjustment for CKM stage, IL-6 at or above the median was associated with higher risks of atherosclerotic CVD (hazard ratio, 1.48; 95% CI, 1.33-1.64), heart failure (1.69; 1.41-2.03), and mortality (1.48; 1.36-1.61); hsCRP associations were smaller. IL-6 showed additive effect modification with CKM stage for atherosclerotic CVD (relative excess risk due to interaction, 0.81; 95% CI, 0.17-1.46) but no multiplicative effect modification (P = 0.59), and no effect modification for heart failure or mortality. hsCRP showed no consistent effect modification. Conclusions Higher IL-6 and hsCRP were each associated with higher cardiovascular and mortality risks independent of early-stage CKM syndrome. IL-6 showed additive effect modification with CKM stage for atherosclerotic CVD, indicating a positive relative excess risk due to interaction among adults with CKM stages 2-3.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。